Capital Fund Management (CFM)’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Capital Fund Management (CFM)’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-3,800	Closed	-$239K	–	1680
2020 Q1	$239K	Buy	3,800 +1,100	+41%	+$98.9K	﹤0.01%	1328
2019 Q4	$335K	Sell	2,700 -1,500	-36%	-$134K	﹤0.01%	1562
2019 Q3	$279K	Buy	+4,200	New	+$282K	﹤0.01%	1454
2018 Q4	–	Sell	-5,100	Closed	-$644K	–	2303
2018 Q3	$644K	Buy	+5,100	New	+$540K	﹤0.01%	1511
2018 Q2	–	Sell	-4,200	Closed	-$258K	–	2343
2018 Q1	$258K	Sell	4,200 -14,200	-77%	-$856K	﹤0.01%	1681
2017 Q4	$1.07M	Buy	+18,400	New	+$1.16M	0.01%	1191
2017 Q1	–	Sell	-4,800	Closed	-$522K	–	1919
2016 Q4	$522K	Buy	+4,800	New	+$572K	﹤0.01%	1250
2016 Q3	–	Sell	-3,600	Closed	-$514K	–	1847
2016 Q2	$514K	Buy	+3,600	New	+$525K	﹤0.01%	1160
2015 Q3	–	Sell	-1,800	Closed	-$434K	–	1731
2015 Q2	$434K	Buy	+1,800	New	+$479K	0.01%	1129

Other funds holding ICPT

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

EAM

EULAV Asset Management Sarasota, Florida $3.13B AUM 23.04% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Fund Management (CFM)'s ICPT Position: Q3 2021 in Review

Capital Fund Management (CFM) sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q3 2021, closing a stake of 19,683 shares — an estimated $393K sold.

Capital Fund Management (CFM) first reported a position in ICPT in Q2 2014 and held it in 13 quarters. The position peaked at $5.84M in Q2 2014. 139 funds tracked by Wall St. Rank hold ICPT as of Q3 2021.

Capital Fund Management (CFM) reported no remaining Intercept Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
Capital Fund Management (CFM) sold 19,683 Intercept Pharmaceuticals, Inc. shares in Q3 2021, an estimated $393K.
Capital Fund Management (CFM) first reported a position in Intercept Pharmaceuticals, Inc. in Q2 2014 and held it in 13 quarters.
Capital Fund Management (CFM)'s Intercept Pharmaceuticals, Inc. position peaked at $5.84M in Q2 2014.
139 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q3 2021.

Based on Capital Fund Management (CFM)'s 13F filing for Q3 2021, filed 12 Nov 2021.